Show simple item record

dc.contributor.authorGupta, Shashi
dc.contributor.authorSeth, Alpna
dc.contributor.authorDavis, Roger J.
dc.date2022-08-11T08:08:58.000
dc.date.accessioned2022-08-23T16:14:10Z
dc.date.available2022-08-23T16:14:10Z
dc.date.issued1993-04-15
dc.date.submitted2008-09-23
dc.identifier.citation<p>Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3216-20.</p>
dc.identifier.issn0027-8424 (Print)
dc.identifier.doi10.1073/pnas.90.8.3216
dc.identifier.pmid8386367
dc.identifier.urihttp://hdl.handle.net/20.500.14038/33799
dc.description.abstractThe product of the human c-myc protooncogene (Myc) is a sequence-specific DNA binding protein. Here, we demonstrate that the placement of the specific Myc DNA binding site CACGTG upstream of a luciferase reporter gene conferred Myc-stimulated expression that was inhibited by the overexpression of the basic-helix-loop-helix/leucine zipper protein Max. It was observed that Myc was phosphorylated in vivo within the NH2-terminal domain at Thr-58 and Ser-62. Replacement of these phosphorylation sites with Ala residues caused a marked decrease in Myc-stimulated reporter gene expression. In contrast, the replacement of Thr-58 or Ser-62 with an acidic residue (Glu) caused only a small inhibition of transactivation. Together, these data demonstrate that the NH2-terminal phosphorylation sites Thr-58 and Ser-62 are required for high levels of transactivation of gene expression by Myc.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8386367&dopt=Abstract">Link to article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC46270/
dc.subjectAmino Acid Sequence; Animals; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cercopithecus aethiops; Codon; DNA; Gene Expression; Genes, myc; Humans; Molecular Sequence Data; *Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Phosphorylation; Plasmids; Point Mutation; Polymerase Chain Reaction; Protein Kinases; Proto-Oncogene Proteins c-myc; *Serine; Substrate Specificity; *Threonine; *Trans-Activation (Genetics)
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleTransactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62
dc.typeJournal Article
dc.source.journaltitleProceedings of the National Academy of Sciences of the United States of America
dc.source.volume90
dc.source.issue8
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/460
dc.identifier.contextkey635955
html.description.abstract<p>The product of the human c-myc protooncogene (Myc) is a sequence-specific DNA binding protein. Here, we demonstrate that the placement of the specific Myc DNA binding site CACGTG upstream of a luciferase reporter gene conferred Myc-stimulated expression that was inhibited by the overexpression of the basic-helix-loop-helix/leucine zipper protein Max. It was observed that Myc was phosphorylated in vivo within the NH2-terminal domain at Thr-58 and Ser-62. Replacement of these phosphorylation sites with Ala residues caused a marked decrease in Myc-stimulated reporter gene expression. In contrast, the replacement of Thr-58 or Ser-62 with an acidic residue (Glu) caused only a small inhibition of transactivation. Together, these data demonstrate that the NH2-terminal phosphorylation sites Thr-58 and Ser-62 are required for high levels of transactivation of gene expression by Myc.</p>
dc.identifier.submissionpathgsbs_sp/460
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages3216-20


This item appears in the following Collection(s)

Show simple item record